At Algae4IBD, we develop new solutions to prevent and treat pain, inflammation and inflammatory bowel disease (IBD) by harnessing the health potential of algae.
Because, micro- and macroalgae produce compounds that can relieve pain and inflammation. To identify these compounds we cultivate different algae species. With the identified compounds, we will develop new functional food and medication bringing the health benefit from the ocean to the people.
Thereby, we focus especially on IBD. Globally, more than 6.8 million kids and adults suffer from this disease. IBD comprises a group of chronic disorders of the gastrointestinal tract. The two most common forms are ulcerative colitis and Crohn’s disease. The currently, available treatments do not work for everyone, making new options necessary.
Read more about Algae4IBD on our website.
H2020-funded: 101000501
Company Details
- Founded
- -
- Address
- Migal Building, Southern Industrial Zone, Tarshish St., Qiryat Shemona,israel
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://algae4ibd.eu/
- HQ
- Qiryat Shemona
Algae4ibd Questions
Algae4Ibd's website is https://algae4ibd.eu/
Algae4Ibd's LinkedIn profile is https://il.linkedin.com/company/algae4ibd
Algae4Ibd's industry is
Research Services
Algae4Ibd's top competitors are
Algaplus Production And Trading Of Seaweed And Derived Products S.a.,
Agromix Project,
Realm Algae,
Aliga Microalgae,
Algaia - Jrs Group,
Phytobloom - Microalgae By Necton,
A4f-Algae For Future,
Centre Of Marine Sciences (Ccmar),
Marbiotech Research Group,
Algae Vertical.
Algae4Ibd's categories are Research Services
Algae4Ibd's founding year is 2021
